Drug Discovery for Leishmaniasis
Herausgeber: Rivas, Luis; Gil, Carmen
Drug Discovery for Leishmaniasis
Herausgeber: Rivas, Luis; Gil, Carmen
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania.
Andere Kunden interessierten sich auch für
- Peptide-Based Drug Discovery259,99 €
- Advances in Nucleic Acid Therapeutics283,99 €
- Drug Transporters259,99 €
- Accounts in Drug Discovery192,99 €
- Platform Technologies in Drug Discovery and Validation122,99 €
- Epigenetics for Drug Discovery259,99 €
- The Biological Chemistry of Nickel245,99 €
-
-
-
Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania.
Produktdetails
- Produktdetails
- Drug Discovery
- Verlag: Royal Society of Chemistry
- Seitenzahl: 422
- Erscheinungstermin: 1. November 2017
- Englisch
- Abmessung: 234mm x 163mm x 28mm
- Gewicht: 788g
- ISBN-13: 9781782628897
- ISBN-10: 1782628894
- Artikelnr.: 48813788
- Drug Discovery
- Verlag: Royal Society of Chemistry
- Seitenzahl: 422
- Erscheinungstermin: 1. November 2017
- Englisch
- Abmessung: 234mm x 163mm x 28mm
- Gewicht: 788g
- ISBN-13: 9781782628897
- ISBN-10: 1782628894
- Artikelnr.: 48813788
Leishmaniasis, Impact and Therapeutic Needs; Anti-leishmanial Drug
Discovery: Past, Present and Future Perspectives; From Bench to Bedside:
Development and Optimization of Clinical Therapies for Visceral
Leishmaniasis; Drug Assay Methodology in Leishmaniasis: From the Microplate
to Image Analysis; The Pursuit of Novel Anti-leishmanial Agents by
High-throughput Screening (HTS) of Chemical Libraries; Omics and Their
Impact on the Development of Chemotherapy Against Leishmania; In silico
Tools for Target Identification and Drug Molecular Docking in Leishmania;
Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs;
Natural Products as a Source of New Drugs Against Leishmania;
Organometallic Compounds in Chemotherapy Against Leishmania; New Avenues
for Drug Delivery in Leishmania: Using Treatment of Visceral Leishmaniasis
with Amphotericin B as an Exemplar; Addressing the Molecular Biology of
Leishmania for Drug Development; The Physical Matrix of the Plasma Membrane
as a Target: The Charm of Drugs with Low Specificity; Nutrient Transport
and Sensing as Pharmacological Targets for Leishmaniasis; Carbon Metabolism
as a Drug Target in Leishmania; The Redox Metabolism and Oxidative Stress
in Leishmania as a Crossroads for the Lethal Effect of Drugs; DNA
Topoisomerases as Promising Targets for Leishmania Chemotherapy; Molecular
Basis of Drug Resistance in Leishmania; The Macrophage-Parasite Interface
as a Chemotherapeutic Target in Leishmaniasis
Discovery: Past, Present and Future Perspectives; From Bench to Bedside:
Development and Optimization of Clinical Therapies for Visceral
Leishmaniasis; Drug Assay Methodology in Leishmaniasis: From the Microplate
to Image Analysis; The Pursuit of Novel Anti-leishmanial Agents by
High-throughput Screening (HTS) of Chemical Libraries; Omics and Their
Impact on the Development of Chemotherapy Against Leishmania; In silico
Tools for Target Identification and Drug Molecular Docking in Leishmania;
Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs;
Natural Products as a Source of New Drugs Against Leishmania;
Organometallic Compounds in Chemotherapy Against Leishmania; New Avenues
for Drug Delivery in Leishmania: Using Treatment of Visceral Leishmaniasis
with Amphotericin B as an Exemplar; Addressing the Molecular Biology of
Leishmania for Drug Development; The Physical Matrix of the Plasma Membrane
as a Target: The Charm of Drugs with Low Specificity; Nutrient Transport
and Sensing as Pharmacological Targets for Leishmaniasis; Carbon Metabolism
as a Drug Target in Leishmania; The Redox Metabolism and Oxidative Stress
in Leishmania as a Crossroads for the Lethal Effect of Drugs; DNA
Topoisomerases as Promising Targets for Leishmania Chemotherapy; Molecular
Basis of Drug Resistance in Leishmania; The Macrophage-Parasite Interface
as a Chemotherapeutic Target in Leishmaniasis
Leishmaniasis, Impact and Therapeutic Needs; Anti-leishmanial Drug
Discovery: Past, Present and Future Perspectives; From Bench to Bedside:
Development and Optimization of Clinical Therapies for Visceral
Leishmaniasis; Drug Assay Methodology in Leishmaniasis: From the Microplate
to Image Analysis; The Pursuit of Novel Anti-leishmanial Agents by
High-throughput Screening (HTS) of Chemical Libraries; Omics and Their
Impact on the Development of Chemotherapy Against Leishmania; In silico
Tools for Target Identification and Drug Molecular Docking in Leishmania;
Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs;
Natural Products as a Source of New Drugs Against Leishmania;
Organometallic Compounds in Chemotherapy Against Leishmania; New Avenues
for Drug Delivery in Leishmania: Using Treatment of Visceral Leishmaniasis
with Amphotericin B as an Exemplar; Addressing the Molecular Biology of
Leishmania for Drug Development; The Physical Matrix of the Plasma Membrane
as a Target: The Charm of Drugs with Low Specificity; Nutrient Transport
and Sensing as Pharmacological Targets for Leishmaniasis; Carbon Metabolism
as a Drug Target in Leishmania; The Redox Metabolism and Oxidative Stress
in Leishmania as a Crossroads for the Lethal Effect of Drugs; DNA
Topoisomerases as Promising Targets for Leishmania Chemotherapy; Molecular
Basis of Drug Resistance in Leishmania; The Macrophage-Parasite Interface
as a Chemotherapeutic Target in Leishmaniasis
Discovery: Past, Present and Future Perspectives; From Bench to Bedside:
Development and Optimization of Clinical Therapies for Visceral
Leishmaniasis; Drug Assay Methodology in Leishmaniasis: From the Microplate
to Image Analysis; The Pursuit of Novel Anti-leishmanial Agents by
High-throughput Screening (HTS) of Chemical Libraries; Omics and Their
Impact on the Development of Chemotherapy Against Leishmania; In silico
Tools for Target Identification and Drug Molecular Docking in Leishmania;
Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs;
Natural Products as a Source of New Drugs Against Leishmania;
Organometallic Compounds in Chemotherapy Against Leishmania; New Avenues
for Drug Delivery in Leishmania: Using Treatment of Visceral Leishmaniasis
with Amphotericin B as an Exemplar; Addressing the Molecular Biology of
Leishmania for Drug Development; The Physical Matrix of the Plasma Membrane
as a Target: The Charm of Drugs with Low Specificity; Nutrient Transport
and Sensing as Pharmacological Targets for Leishmaniasis; Carbon Metabolism
as a Drug Target in Leishmania; The Redox Metabolism and Oxidative Stress
in Leishmania as a Crossroads for the Lethal Effect of Drugs; DNA
Topoisomerases as Promising Targets for Leishmania Chemotherapy; Molecular
Basis of Drug Resistance in Leishmania; The Macrophage-Parasite Interface
as a Chemotherapeutic Target in Leishmaniasis